查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1981584

黃酮類化合物市場：2026-2032年全球市場預測（按類型、原料、配方、萃取方法、應用和分銷管道分類）

Flavones Market by Type, Source, Formulation, Extraction Method, Application, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，黃酮市場價值將達到 23.4 億美元，到 2026 年將成長到 25.2 億美元，到 2032 年將達到 39.2 億美元，複合年成長率為 7.59%。

主要市場統計數據
基準年 2025 23.4億美元
預計年份：2026年 25.2億美元
預測年份：2032年 39.2億美元
複合年成長率 (%) 7.59%

簡明扼要地概述了黃酮類化合物，將科學特性與商業性重點相結合，面向配方開發負責人、採購團隊和監管負責人。

黃酮類化合物是一類植物來源的多酚化合物，在配方研發創新、監管監管和供應鏈重組這三大因素的交會點上，其重要性日益凸顯。黃酮類化合物具有廣泛的功能特性，包括抗氧化作用、紫外線吸收和生物活性調節等，使其成為化妝品、食品、營養保健品和藥品製劑中用途廣泛的成分。隨著創新週期的加速，產品開發人員和採購團隊面臨著相互衝突的壓力，既要兼顧功效、可追溯性和成本，也要滿足消費者對天然和永續來源的期望。

提取技術的進步、更嚴格的監管以及不斷變化的消費者期望，是如何重塑整個黃酮價值鏈的供應鏈和配方策略的？

在科技、法規和消費趨勢的共同驅動下，黃酮類化合物的市場環境正經歷著變革性的變化。技術方面，萃取和純化技術的進步，特別是超臨界二氧化碳萃取和酵素法製程的成熟，正在改變成本結構，並實現高純度分離物的生產。這拓展了注射劑和外用製劑等敏感應用領域的配方可能性。同時，在化妝品和營養補充劑配方改良的趨勢下，原料來源和功效的檢驗日益重要，這就要求供應商接受更嚴格的合格評估，並由第三方機構進行檢驗。

我們評估關稅變化和貿易政策調整如何促使黃酮類化合物業務部門修改其採購結構、實施成本削減措施並加強策略供應鏈的韌性。

針對性貿易措施和關稅調整的累積效應可能會重塑多個領域的供應商經濟、原料流動和策略採購決策。近期針對進口植物萃取物和前驅物原料的關稅措施給採購團隊帶來了多方面的壓力。具體而言，這些壓力包括接收成本增加、對替代供應商的需求增加以及對國內生產和本地加工的關注度加快。這些趨勢對涉及多個司法管轄區、涉及多個加工環節的複雜供應鏈的影響尤其顯著。

細分市場情報透過協調類黃酮化學類型、來源地、特定用途限制、製劑形式、提取技術和分銷管道來完善策略。

結構化的市場細分觀點揭示了影響黃酮類化合物需求和供應商行為的因素在類型、來源、應用、配方、萃取方法和分銷管道等方面的差異。在考慮類型時，產品開發團隊應評估每種芹菜素、黃芩苷、白楊素、二氫黃酮、木犀草素和橘皮素的獨特理化性質和生物活性特徵，因為每種類型都具有其獨特的穩定性、溶解性和功能特性，這些特性會影響配方選擇和監管測試要求。天然來源和合成原料來源之間的差異會影響消費者對產品功效的認知、可追溯性義務和合規管道，尤其是在天然來源具有市場優勢或需要更嚴格驗證植物來源真實性的市場中。

美洲、歐洲、中東和非洲以及亞太地區的商業環境和需求因素決定了採購、合規和商業化的優先事項。

黃酮類化合物的區域趨勢反映了原料供應狀況、生產能力、法律規範和消費模式等多種因素的綜合影響。在美洲，健康意識強的消費者群體和成熟的機能性食品生態系統正強勁推動市場需求，配方創新主要集中在口服補充劑和機能飲料領域。北美監管機構優先考慮可靠的安全資料和透明度，因此增加了對分析檢驗和供應商審核的投入。同時，美洲部分次區域的工業加工能力支持通用黃酮衍生物的大規模生產，但人們也越來越關注本地高純度加工，以降低跨境物流風險。

原料供應商、萃取商和製劑製造商之間的競爭定位和能力趨勢，透過競爭、可追溯性和先進的製劑技術來實現差異化。

黃酮生態系統中的主要企業擁有多元化的能力，使其績效脫穎而出。這些能力包括整合原料採購和內部提取能力的一體化供應鏈、先進的分析和配方開發，以及強大的法規遵循團隊。這些能力能夠加速產品部署，並降低滿足嚴格的特定應用規格所需的時間和成本。整個產業普遍採取的策略性措施包括：有針對性地收購以加強關鍵植物原料的供應；與原料技術專家共同開發契約；以及投資於專有的萃取平台，以實現更高的產量和更純淨的雜質含量。

可立即實施的跨部門行動，以增強供應鏈韌性，加快產品開發，並提高對監管合規性和永續性的信心。

產業領導企業應優先採取一系列切實可行的措施，抓住短期機遇，同時建構長期競爭優勢。首先，透過核實關鍵植物性原料的二級和三級原料的合格，並記錄替代供應路線，加強供應商多元化。這可以降低單點故障（SPOF）的風險，並增強合約談判中的議價能力。其次，加速對環保、高選擇性萃取技術的投資，以實現更高的純度，並滿足日益成長的永續發展期望。這將有助於在天然來源聲明中獲得高階定位。

簡要概述了將技術進步、供應彈性和監管準備轉化為可操作的商業性步驟所面臨的策略挑戰。

總而言之，儘管黃酮類化合物市場在供應、監管和商業方面錯綜複雜，但仍蘊藏著多方面的機會。提取和配方技術的進步正在開闢新的應用管道，而日益嚴格的監管和貿易政策的變化也帶來了營運上的限制，需要企業採取積極主動的策略。那些將嚴謹的科學方法與完善的採購系統、可靠的文件和精準的商業模式相結合的企業，更有可能抓住市場機遇，最大限度地減少市場摩擦。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 工業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：黃酮市場：按類型分類

  • 芹菜素
  • 黃芩苷
  • 克里斯汀
  • 地奧司明
  • 木犀草素
  • 橘皮苷

第9章：黃酮市場：依原料分類

  • 自然的
  • 合成

第10章：黃酮市場：以劑型分類

  • 膠囊
  • 液體
  • 粉末
  • 藥片

第11章 黃酮市場：依提取方法分類

  • 酵素提取
  • 溶劑萃取
  • 超臨界二氧化碳

第12章：類黃酮市場：依應用領域分類

  • 化妝品
    • 護髮
    • 化妝品
    • 護膚
  • 飲食
    • 麵包店
    • 飲料
    • 糖果甜點
    • 乳製品
  • 營養補充品
    • 飲料
    • 營養補充品
    • 機能性食品
  • 製藥
    • 注射藥物
    • 口服藥物
    • 外用藥物

第13章：類黃酮市場：依通路分類

  • 直銷
  • 線上
  • 零售

第14章：類黃酮市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章：黃酮市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章：黃酮市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國黃酮市場

第18章：中國黃酮市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alchem International Pvt Ltd
  • BASF SE
  • Biosynth Ltd.
  • ChromaDex, Inc
  • Euromed SA
  • Givaudan SA
  • Hunan Nutramax Inc.
  • Indena SpA
  • International Flavors & Fragrances Inc.
  • J& K Scientific Ltd.
  • Koninklijke DSM NV
  • Martin Bauer GmbH
  • MedChemExpress
  • Nacalai Tesque, Inc.
  • NANS PRODUCTS
  • Nutralliance Inc.
  • Santa Cruz BIoTechnology, Inc.
  • Xi'an Sgonek Health Industry Co., Ltd.
  • Zhejiang NHU Company Limited
Product Code: MRR-521BAA36ECE6

The Flavones Market was valued at USD 2.34 billion in 2025 and is projected to grow to USD 2.52 billion in 2026, with a CAGR of 7.59%, reaching USD 3.92 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.34 billion
Estimated Year [2026] USD 2.52 billion
Forecast Year [2032] USD 3.92 billion
CAGR (%) 7.59%

A concise orientation to flavones that aligns scientific attributes with commercial priorities for formulation leaders, procurement teams, and regulatory strategists

Flavones are a class of plant-derived polyphenolic compounds that increasingly sit at the intersection of formulation innovation, regulatory scrutiny, and supply chain reconfiguration. Their broad functional attributes-ranging from antioxidative potential to UV absorption characteristics and bioactive modulation-have positioned flavones as versatile ingredients in cosmetics, food systems, nutraceuticals, and pharmaceutical formulations. As innovation cycles accelerate, product developers and procurement teams face competing pressures to balance efficacy, traceability, and cost while meeting evolving consumer expectations around natural origins and sustainable sourcing.

This executive summary maps the contemporary landscape for flavones with a focus on actionable insights for commercial leaders. It highlights pivotal shifts in sourcing and extraction technologies, regulatory considerations that shape formulation choices, and segmentation layers that inform go-to-market strategies. Throughout, emphasis is placed on practical implications for product development, supplier engagement, and cross-border trade dynamics, so readers can translate analytical findings into prioritized initiatives without delay.

By clarifying where scientific opportunity aligns with commercial readiness and by identifying operational levers that reduce time-to-market, this introduction frames a concise agenda for leadership teams seeking to capitalize on flavone utility while mitigating supply-side and compliance risks.

How advances in extraction technologies, regulatory tightening, and shifting consumer expectations are reshaping supply chains and formulation strategies across the flavone value chain

The landscape for flavones is undergoing transformative shifts driven by technological, regulatory, and consumer-facing dynamics. On the technology front, advances in extraction and purification-particularly the maturation of supercritical CO2 and enzymatic processes-are altering cost structures and enabling higher-purity isolates that expand formulation possibilities in sensitive applications such as injectables and topical therapeutics. At the same time, reformulation trends within cosmetics and nutraceuticals prioritize ingredient provenance and efficacy validation, prompting more rigorous supplier qualification and third-party testing.

Regulatory evolution is another accelerant. Authorities are increasingly demanding detailed compositional profiles and validated safety data, which elevates the importance of standardized analytical methods and robust documentation across the supply chain. Consequently, companies that invest early in analytical capacity and regulatory dossiers will face shorter approval timelines and fewer post-launch disruptions. Furthermore, consumer expectations for natural, traceable, and sustainably produced ingredients are shifting procurement decisions toward verified natural sources and transparent extraction methods.

Finally, macro-level supply chain realignments-including nearshoring and supplier diversification driven by geopolitical tensions-are prompting more resilient sourcing strategies. As a result, firms that combine scientific rigor with strategic sourcing agility are best positioned to convert the evolving flavone landscape into a competitive advantage.

Evaluating how tariff shifts and trade policy adjustments are prompting sourcing realignment, cost mitigation tactics, and strategic supply chain resilience measures in flavones

The cumulative impact of targeted trade measures and tariff adjustments can reshape supplier economics, ingredient flows, and strategic sourcing decisions across multiple segments. Recent tariff actions affecting imported botanical extracts and precursor materials have introduced a multi-dimensional pressure on procurement teams: landed cost increases, demand for alternative suppliers, and accelerated interest in domestic production and in-country processing. These dynamics are particularly consequential for complex supply chains where multiple processing stages occur across jurisdictions.

Operationally, companies are responding by redesigning sourcing portfolios to reduce exposure to a single geography, investing in localized extraction capacity, and negotiating longer-term contracts to stabilize input pricing and availability. In parallel, some formulators are revisiting product specifications to identify where functional performance can be retained with different grades or alternative flavone types that face lower trade friction. Such reformulation strategies require proactive analytical comparability studies to ensure safety and efficacy remain uncompromised.

From a finance and planning perspective, tariff-driven cost inflation is prompting closer collaboration between R&D, procurement, and commercial teams to identify margin-preserving interventions such as blended sourcing, near-term hedging of raw material commitments, and incremental pricing strategies. Taken together, these measures mitigate immediate disruption while creating optionality for longer-term vertical integration or strategic partnerships with raw material processors.

Segmented intelligence that aligns flavone chemotypes, sourcing origin, application-specific constraints, formulation formats, extraction techniques, and distribution channels to refine strategy

A structured segmentation lens reveals differentiated drivers of demand and supplier behaviour across flavone types, sources, applications, formulations, extraction methods, and distribution channels. When considering type, product teams must evaluate the unique physicochemical and bioactive profiles of Apigenin, Baicalin, Chrysin, Diosmetin, Luteolin, and Tangeretin, since each type presents distinct stability, solubility, and functional properties that influence formulation choices and regulatory testing requirements. Source differentiation between natural and synthetic origins carries implications for efficacy perception, traceability obligations, and compliance pathways, particularly in markets where natural sourcing confers marketing advantages or faces stricter botanical authentication.

Application segmentation uncovers nuanced performance and regulatory constraints. Cosmetics applications demand dermatological compatibility and often prioritize ingredient aesthetics and sensory outcomes across haircare, makeup, and skincare formats. Food and beverage applications require food-grade specifications and process compatibility for bakery, beverages, confectionery, and dairy matrices. Nutraceutical formats span beverages, dietary supplements, and functional foods, where bioavailability and clean-label positioning are critical. Pharmaceuticals impose the most stringent purity and safety standards across injectable drugs, oral drugs, and topical drugs, necessitating rigorous GMP-compliant manufacturing and validated analytical methods.

Formulation choices-whether capsule, liquid, powder, or tablet-shape bioavailability strategies and manufacturing constraints, while extraction methods such as enzymatic processes, solvent extraction, and supercritical CO2 determine impurity profiles, solvent residues, and sustainability credentials. Finally, distribution channels including direct sales, online platforms, and retail outlets influence commercialization timelines, packaging needs, and regulatory labeling practices. Integrating these segmentation axes enables targeted product development roadmaps and supplier qualification criteria aligned to each commercial channel and end-use requirement.

Regional operating realities and demand drivers across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine sourcing, compliance, and commercialization priorities

Regional dynamics for flavones reflect a mix of raw material endowment, manufacturing capability, regulatory frameworks, and consumption patterns. In the Americas, demand is strongly driven by health-conscious consumer segments and an advanced nutraceutical ecosystem, with formulation innovation concentrated in oral supplements and functional beverages. North American regulatory expectations emphasize robust safety dossiers and transparency, prompting higher investment in analytical validation and supplier audits. Meanwhile, industrial processing capabilities in certain American subregions support scale production for commodity flavone derivatives, but there is also accelerating interest in localized high-purity processing to reduce cross-border logistics exposure.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory stringency, sustainability mandates, and premium cosmetic markets intersect. European markets, in particular, prioritize environmental impact, certifications, and provenance claims, which elevates demand for certified natural extracts and green extraction techniques. Regulatory harmonization efforts across the region are encouraging standardized testing and documentation, though local nuances in labeling and claims enforcement require tailored go-to-market tactics. Across some Middle Eastern and African markets, emerging consumer segments and expanding pharmaceutical manufacturing capacity create opportunities for targeted partnerships and capacity-building initiatives.

Asia-Pacific remains a critical region for both upstream supply and downstream demand. Extensive botanical resources and a dense network of extractors underpin raw material availability, while growing middle-class consumption fuels demand for functional foods, cosmetics, and nutraceuticals. Regulatory regimes vary significantly, necessitating bespoke regulatory strategies that account for country-specific approvals, pharmacopeial standards, and import controls. Taken together, regional strategy should blend local supply advantages with compliance foresight and market-specific product positioning.

Competitive positioning and capability patterns among ingredient suppliers, extractors, and formulators that drive differentiation through integration, traceability, and advanced formulation expertise

Leading firms in the flavone ecosystem exhibit a mix of capabilities that differentiate performance: integrated supply chains that combine raw material sourcing with in-house extraction capacity, advanced analytical and formulation R&D, and robust regulatory affairs teams. These capabilities accelerate product introductions and reduce the time and cost required to meet rigorous application-specific specifications. Strategic moves observed across the industry include targeted acquisitions to shore up supply of key botanicals, co-development agreements with ingredient technology specialists, and investments in proprietary extraction platforms that deliver higher yields and cleaner impurity profiles.

Competitive advantage is increasingly tied to the ability to provide documented traceability, validated sustainability credentials, and consistent batch-to-batch quality. As a result, companies investing in enhanced traceability systems and certification schemes gain access to premium channels that prioritize provenance. Additionally, firms that establish close collaborative relationships with contract manufacturers, contract research organizations, and academic partners can accelerate translational research efforts-transforming laboratory-level efficacy into scalable, compliant products. Finally, nimble commercial strategies that combine direct customer engagement with selective digital distribution allow companies to efficiently test novel applications while controlling margin outcomes.

Practical, cross-functional actions that can be implemented immediately to build supply resilience, accelerate product development, and elevate regulatory and sustainability credentials

Industry leaders should prioritize a set of actionable initiatives to capture near-term opportunities while building durable advantages. First, strengthen supplier diversification by qualifying secondary and tertiary sources for critical botanicals while documenting alternative supply routes; this reduces single-point-of-failure risk and creates leverage in contract negotiations. Second, accelerate investments in green and high-selectivity extraction technologies to achieve better purity profiles and to meet rising sustainability expectations, thereby enabling premium positioning for natural-origin claims.

Third, align cross-functional teams-R&D, regulatory, procurement, and commercial-to run parallel experiments that evaluate formulation equivalence across different flavone types and grades. This approach permits rapid substitution where tariffs or supply constraints arise without compromising product performance. Fourth, enhance analytical and documentation capabilities to support regulatory submissions and to underpin marketing claims; validated methods for impurity profiling and stability testing will shorten approval cycles and reduce post-market risk. Finally, pursue strategic partnerships with contract manufacturers and distribution specialists to accelerate market entry, supported by flexible commercial agreements that share development costs and risk.

This report's conclusions are derived from a mixed-methods research approach that balances empirical evidence with expert judgment to ensure robust, actionable insights. The methodology combined comprehensive secondary analysis of scientific literature, patent filings, regulatory guidance documents, and trade announcements with structured primary interviews conducted across supply chain stakeholders, formulation scientists, procurement leaders, and regulatory specialists. Data triangulation was applied to reconcile differences between supplier-reported capabilities, independent lab findings, and application-specific performance metrics.

Analytical protocols included comparative assessments of extraction methods, laboratory comparability testing to evaluate type- and grade-specific functionality, and scenario modeling to explore supply disruption pathways and mitigation levers. Quality assurance processes encompassed peer review by domain experts, reproducibility checks for key laboratory-derived performance claims, and an audit trail linking primary source materials to synthesized findings. Wherever possible, evidence was validated across multiple independent sources to reduce bias and to surface the most reliable operational recommendations for commercial decision-makers.

A concise synthesis of strategic imperatives that connects technical advances, supply resilience, and regulatory preparedness to executable commercial steps

In synthesis, the flavones landscape offers multi-dimensional opportunity tempered by supply, regulatory, and commercial complexity. Scientific advances in extraction and formulation open new application pathways, while regulatory tightening and trade policy shifts impose operational constraints that demand proactive strategy. Companies that integrate scientific rigor with resilient sourcing, robust documentation, and targeted commercial models will be best positioned to capture value and reduce time-to-market friction.

Strategically, the imperative is to convert technical differentiation into scalable advantage through deliberate investments in extraction technologies, analytical capability, and strategic supplier relationships. Operationally, contingencies for trade-related disruptions and local regulatory nuances should be embedded into procurement and R&D planning. Ultimately, success will hinge on the ability of organizations to move from insight to execution-rapidly validating alternatives, securing traceable supply lines, and aligning product claims with demonstrable performance-while maintaining a clear focus on consumer trust and regulatory compliance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Flavones Market, by Type

  • 8.1. Apigenin
  • 8.2. Baicalin
  • 8.3. Chrysin
  • 8.4. Diosmetin
  • 8.5. Luteolin
  • 8.6. Tangeretin

9. Flavones Market, by Source

  • 9.1. Natural
  • 9.2. Synthetic

10. Flavones Market, by Formulation

  • 10.1. Capsule
  • 10.2. Liquid
  • 10.3. Powder
  • 10.4. Tablet

11. Flavones Market, by Extraction Method

  • 11.1. Enzymatic
  • 11.2. Solvent Extraction
  • 11.3. Supercritical CO2

12. Flavones Market, by Application

  • 12.1. Cosmetics
    • 12.1.1. Haircare
    • 12.1.2. Makeup
    • 12.1.3. Skincare
  • 12.2. Food And Beverages
    • 12.2.1. Bakery
    • 12.2.2. Beverages
    • 12.2.3. Confectionery
    • 12.2.4. Dairy
  • 12.3. Nutraceuticals
    • 12.3.1. Beverages
    • 12.3.2. Dietary Supplements
    • 12.3.3. Functional Foods
  • 12.4. Pharmaceuticals
    • 12.4.1. Injectable Drugs
    • 12.4.2. Oral Drugs
    • 12.4.3. Topical Drugs

13. Flavones Market, by Distribution Channel

  • 13.1. Direct Sales
  • 13.2. Online
  • 13.3. Retail

14. Flavones Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Flavones Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Flavones Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Flavones Market

18. China Flavones Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Alchem International Pvt Ltd
  • 19.6. BASF SE
  • 19.7. Biosynth Ltd.
  • 19.8. ChromaDex, Inc,
  • 19.9. Euromed S.A.
  • 19.10. Givaudan S.A.
  • 19.11. Hunan Nutramax Inc.
  • 19.12. Indena S.p.A.
  • 19.13. International Flavors & Fragrances Inc.
  • 19.14. J&K Scientific Ltd.
  • 19.15. Koninklijke DSM N.V.
  • 19.16. Martin Bauer GmbH
  • 19.17. MedChemExpress
  • 19.18. Nacalai Tesque, Inc.
  • 19.19. NANS PRODUCTS
  • 19.20. Nutralliance Inc.
  • 19.21. Santa Cruz Biotechnology, Inc.
  • 19.22. Xi'an Sgonek Health Industry Co., Ltd.
  • 19.23. Zhejiang NHU Company Limited

LIST OF FIGURES

  • FIGURE 1. GLOBAL FLAVONES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL FLAVONES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL FLAVONES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL FLAVONES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL FLAVONES MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL FLAVONES MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL FLAVONES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL FLAVONES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL FLAVONES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL FLAVONES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES FLAVONES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA FLAVONES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL FLAVONES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL FLAVONES MARKET SIZE, BY APIGENIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL FLAVONES MARKET SIZE, BY APIGENIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL FLAVONES MARKET SIZE, BY APIGENIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL FLAVONES MARKET SIZE, BY BAICALIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL FLAVONES MARKET SIZE, BY BAICALIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL FLAVONES MARKET SIZE, BY BAICALIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL FLAVONES MARKET SIZE, BY CHRYSIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL FLAVONES MARKET SIZE, BY CHRYSIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL FLAVONES MARKET SIZE, BY CHRYSIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL FLAVONES MARKET SIZE, BY DIOSMETIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL FLAVONES MARKET SIZE, BY DIOSMETIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL FLAVONES MARKET SIZE, BY DIOSMETIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL FLAVONES MARKET SIZE, BY LUTEOLIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FLAVONES MARKET SIZE, BY LUTEOLIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FLAVONES MARKET SIZE, BY LUTEOLIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FLAVONES MARKET SIZE, BY TANGERETIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FLAVONES MARKET SIZE, BY TANGERETIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FLAVONES MARKET SIZE, BY TANGERETIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL FLAVONES MARKET SIZE, BY NATURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL FLAVONES MARKET SIZE, BY NATURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FLAVONES MARKET SIZE, BY NATURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FLAVONES MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FLAVONES MARKET SIZE, BY SYNTHETIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL FLAVONES MARKET SIZE, BY SYNTHETIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL FLAVONES MARKET SIZE, BY CAPSULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL FLAVONES MARKET SIZE, BY CAPSULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL FLAVONES MARKET SIZE, BY CAPSULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL FLAVONES MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL FLAVONES MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL FLAVONES MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL FLAVONES MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL FLAVONES MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL FLAVONES MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL FLAVONES MARKET SIZE, BY TABLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL FLAVONES MARKET SIZE, BY TABLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL FLAVONES MARKET SIZE, BY TABLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL FLAVONES MARKET SIZE, BY ENZYMATIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL FLAVONES MARKET SIZE, BY ENZYMATIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL FLAVONES MARKET SIZE, BY ENZYMATIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL FLAVONES MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL FLAVONES MARKET SIZE, BY SOLVENT EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL FLAVONES MARKET SIZE, BY SOLVENT EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FLAVONES MARKET SIZE, BY SUPERCRITICAL CO2, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FLAVONES MARKET SIZE, BY SUPERCRITICAL CO2, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FLAVONES MARKET SIZE, BY SUPERCRITICAL CO2, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL FLAVONES MARKET SIZE, BY COSMETICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL FLAVONES MARKET SIZE, BY COSMETICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL FLAVONES MARKET SIZE, BY COSMETICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL FLAVONES MARKET SIZE, BY HAIRCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL FLAVONES MARKET SIZE, BY HAIRCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL FLAVONES MARKET SIZE, BY HAIRCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL FLAVONES MARKET SIZE, BY MAKEUP, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL FLAVONES MARKET SIZE, BY MAKEUP, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL FLAVONES MARKET SIZE, BY MAKEUP, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL FLAVONES MARKET SIZE, BY SKINCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL FLAVONES MARKET SIZE, BY SKINCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL FLAVONES MARKET SIZE, BY SKINCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL FLAVONES MARKET SIZE, BY BAKERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FLAVONES MARKET SIZE, BY BAKERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FLAVONES MARKET SIZE, BY BAKERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FLAVONES MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL FLAVONES MARKET SIZE, BY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL FLAVONES MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL FLAVONES MARKET SIZE, BY CONFECTIONERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL FLAVONES MARKET SIZE, BY CONFECTIONERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL FLAVONES MARKET SIZE, BY CONFECTIONERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL FLAVONES MARKET SIZE, BY DAIRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL FLAVONES MARKET SIZE, BY DAIRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL FLAVONES MARKET SIZE, BY DAIRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FLAVONES MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FLAVONES MARKET SIZE, BY NUTRACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FLAVONES MARKET SIZE, BY NUTRACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL FLAVONES MARKET SIZE, BY BEVERAGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL FLAVONES MARKET SIZE, BY BEVERAGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL FLAVONES MARKET SIZE, BY BEVERAGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL FLAVONES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL FLAVONES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL FLAVONES MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL FLAVONES MARKET SIZE, BY FUNCTIONAL FOODS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL FLAVONES MARKET SIZE, BY FUNCTIONAL FOODS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL FLAVONES MARKET SIZE, BY FUNCTIONAL FOODS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL FLAVONES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL FLAVONES MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL FLAVONES MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FLAVONES MARKET SIZE, BY INJECTABLE DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FLAVONES MARKET SIZE, BY INJECTABLE DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL FLAVONES MARKET SIZE, BY INJECTABLE DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL FLAVONES MARKET SIZE, BY ORAL DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL FLAVONES MARKET SIZE, BY ORAL DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL FLAVONES MARKET SIZE, BY ORAL DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL FLAVONES MARKET SIZE, BY TOPICAL DRUGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL FLAVONES MARKET SIZE, BY TOPICAL DRUGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL FLAVONES MARKET SIZE, BY TOPICAL DRUGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FLAVONES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FLAVONES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FLAVONES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL FLAVONES MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL FLAVONES MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL FLAVONES MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL FLAVONES MARKET SIZE, BY RETAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL FLAVONES MARKET SIZE, BY RETAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL FLAVONES MARKET SIZE, BY RETAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL FLAVONES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS FLAVONES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 128. AMERICAS FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. AFRICA FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL FLAVONES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 209. ASEAN FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 218. GCC FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 219. GCC FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. GCC FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 221. GCC FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 222. GCC FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 223. GCC FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 224. GCC FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 225. GCC FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 226. GCC FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 227. GCC FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPEAN UNION FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPEAN UNION FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPEAN UNION FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPEAN UNION FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPEAN UNION FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPEAN UNION FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. BRICS FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 243. BRICS FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 244. BRICS FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 245. BRICS FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. BRICS FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 247. BRICS FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 248. BRICS FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. G7 FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. G7 FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. G7 FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 254. G7 FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 255. G7 FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 256. G7 FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 257. G7 FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 258. G7 FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 259. G7 FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 260. G7 FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 261. G7 FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 262. NATO FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 263. NATO FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. NATO FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 265. NATO FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 266. NATO FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 267. NATO FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 268. NATO FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 270. NATO FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 271. NATO FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 272. NATO FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL FLAVONES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. UNITED STATES FLAVONES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. UNITED STATES FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. UNITED STATES FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 277. UNITED STATES FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 278. UNITED STATES FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 279. UNITED STATES FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 280. UNITED STATES FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 281. UNITED STATES FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 282. UNITED STATES FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 283. UNITED STATES FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 284. UNITED STATES FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 285. CHINA FLAVONES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. CHINA FLAVONES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 287. CHINA FLAVONES MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 288. CHINA FLAVONES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
  • TABLE 289. CHINA FLAVONES MARKET SIZE, BY EXTRACTION METHOD, 2018-2032 (USD MILLION)
  • TABLE 290. CHINA FLAVONES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 291. CHINA FLAVONES MARKET SIZE, BY COSMETICS, 2018-2032 (USD MILLION)
  • TABLE 292. CHINA FLAVONES MARKET SIZE, BY FOOD AND BEVERAGES, 2018-2032 (USD MILLION)
  • TABLE 293. CHINA FLAVONES MARKET SIZE, BY NUTRACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 294. CHINA FLAVONES MARKET SIZE, BY PHARMACEUTICALS, 2018-2032 (USD MILLION)
  • TABLE 295. CHINA FLAVONES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)